2026 Q2 Portfolio Activity
In 2026 Q2, Novo Holdings A/S maintained a portfolio of 28 distinct positions. The most significant new addition was HEMAB THERAPEUTICS HLDGS INC, now representing 8.92% of the total fund value. They heavily accumulated shares in VIRIDIAN THERAPEUTICS INC, increasing the position by 6.8%. Conversely, Novo Holdings A/S completely exited their position in APOGEE THERAPEUTICS INC.
Position History
hover any row below to update
Loading…
Total Positions
28
Quarter
2026 Q2
Top Holding
EWTX (12.6%)
Top 10 Concentration
73.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-28 of 28
Novo Holdings A/S Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 12.62% | 13.65% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
5,350,000 | $217,370,500 |
$29.72
+43.9%
|
2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
ASML
ASML HOLDING N ...
|
Technology | 10.97% | 10.16% |
#2
1
Prev: #3
|
6.5 |
—
|
no change | no change |
P
S
|
94,946 | $188,889,370 |
$633.67
+167.7%
|
2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
N/A
HEMAB THERAPEUT...
|
|
Unknown | 8.92% | — |
#3
Prev: #—
|
8.1 |
—
|
4,180,550 | — |
NEW
|
4,180,550 | $153,551,602 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
BN
BROOKFIELD CORP
|
Financial Services | 8.68% | 11.46% |
#4
2
Prev: #2
|
5.0 |
—
|
no change | no change |
P
S
|
3,496,245 | $149,534,399 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MPLT
MAPLIGHT THERAP...
|
Healthcare | 7.67% | 6.07% |
#5
Prev: #5
|
4.6 |
—
|
no change | no change |
P
S
|
3,686,622 | $132,128,532 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MIRM
MIRUM PHARMACEU...
|
Healthcare | 7.65% | 9.92% |
#6
2
Prev: #4
|
3.6 |
—
|
-200,000 | -15.1% |
P
S
|
1,125,000 | $131,703,750 | 2019 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
AVALYN PHARMACE...
|
|
Unknown | 7.42% | — |
#7
Prev: #—
|
6.5 |
—
|
3,883,289 | — |
NEW
|
3,883,289 | $127,837,874 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
CRM
SALESFORCE INC
|
Technology | 3.58% | 5.95% |
#8
2
Prev: #6
|
2.4 |
—
|
no change | no change |
P
S
|
393,187 | $61,596,675 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AVBP
ARRIVENT BIOPHA...
|
Healthcare | 3.03% | 3.63% |
#9
2
Prev: #11
|
1.2 |
—
|
-442,142 | -22.8% |
P
S
|
1,500,000 | $52,110,000 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 2.95% | 4.07% |
#10
2
Prev: #8
|
1.2 |
—
|
-280,000 | -21.9% |
P
S
|
1,000,000 | $50,750,000 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CRNX
CRINETICS PHARM...
|
Healthcare | 2.87% | 4.56% |
#11
4
Prev: #7
|
1.6 |
—
|
-230,000 | -14.8% |
P
S
|
1,320,000 | $49,394,400 | 2018 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 2.81% | 4.01% |
#12
2
Prev: #10
|
1.1 |
—
|
-350,000 | -20.0% |
P
S
|
1,400,000 | $48,412,000 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
FND
FLOOR & DECOR H...
|
Consumer Cyclical | 2.75% | — |
#13
Prev: #—
|
4.6 |
—
|
797,000 | — |
NEW
|
797,000 | $47,309,920 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 2.70% | 4.05% |
#14
5
Prev: #9
|
1.6 |
—
|
-60,000 | -7.0% |
P
S
|
800,000 | $46,504,000 | 2020 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
FDMT
4D MOLECULAR TH...
|
Healthcare | 2.51% | 2.75% |
#15
1
Prev: #16
|
1.5 |
—
|
-401,559 | -11.0% |
P
S
|
3,249,178 | $43,214,067 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 2.28% | 3.17% |
#16
4
Prev: #12
|
2.9 |
—
|
135,000 | 6.8% |
P
S
|
2,135,000 | $39,219,950 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 2.21% | 3.08% |
#17
4
Prev: #13
|
1.4 |
—
|
-175,000 | -14.6% |
P
S
|
1,025,000 | $38,140,250 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ALMS
ALUMIS INC
|
Healthcare | 1.80% | — |
#18
Prev: #—
|
4.2 |
—
|
1,100,000 | — |
NEW
|
1,100,000 | $30,954,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 1.70% | 2.29% |
#19
1
Prev: #18
|
1.7 |
—
|
no change | no change |
P
S
|
485,438 | $29,301,038 | 2014 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BABA
ALIBABA GROUP H...
|
Consumer Cyclical | 1.43% | 2.62% |
#20
3
Prev: #17
|
1.6 |
—
|
no change | no change |
P
S
|
257,327 | $24,698,245 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 1.24% | — |
#21
Prev: #—
|
4.0 |
—
|
960,394 | — |
NEW
|
960,394 | $21,330,351 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BBOT
BRIDGEBIO ONCOL...
|
Healthcare | 1.00% | 1.59% |
#22
3
Prev: #19
|
0.9 |
—
|
64,077 | 2.9% |
P
S
|
2,250,000 | $17,145,000 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INSM
INSMED INC
|
Healthcare | 0.75% | — |
#23
Prev: #—
|
3.8 |
—
|
120,723 | — |
NEW
|
120,723 | $12,871,486 | 2020 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MQ
MARQETA INC
|
Technology | 0.42% | 0.15% |
#24
2
Prev: #22
|
1.2 |
—
|
no change | no change |
P
S
|
441,558 | $7,170,902 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LNZA
LANZATECH GLOBA...
|
Industrials | 0.06% | 0.21% |
#25
4
Prev: #21
|
1.0 |
—
|
no change | no change |
P
S
|
158,148 | $1,078,569 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VALN
VALNEVA SE
|
Healthcare | 0.00% | 0.54% |
Sold All 😨
(Was: #20) |
0.0 |
—
|
-1,057,421 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 0.00% | 3.02% |
Sold All 😨
(Was: #15) |
0.0 |
—
|
-660,000 | -100.0% |
CLOSED
|
— | $— | 2022 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
APGE
APOGEE THERAPEU...
|
Healthcare | 0.00% | 3.07% |
Sold All 😨
(Was: #14) |
0.0 |
—
|
-450,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-28 of 28 holdings